...
search icon
avdl-img

Avadel Pharmaceuticals PLC Share Price

AVDL
NMQ
$21.5
-$0.03
(-0.14%)
1D
Industry: Pharmaceuticals Sector: Health Care

Avadel Pharmaceuticals PLC Analyst Forecast

Avadel Pharmaceuticals PLC Share Price Chart

Avadel Pharmaceuticals PLC Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.11B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
576.14K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$6.38 L
$23.57 H
$21.5

About Avadel Pharmaceuticals PLC, Common Stock

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland. more

Industry: PharmaceuticalsSector: Health Care

Avadel Pharmaceuticals PLC Stock Returns

Time FrameAVDLSectorS&P500
1-Week Return0.23%1.64%-0.4%
1-Month Return-0.05%2.13%0.14%
3-Month Return16%8.39%2.61%
6-Month Return94.49%16.16%8.7%
1-Year Return171.16%9.86%13%
3-Year Return208.01%17.8%72.1%
5-Year Return216.15%33.74%79.31%
10-Year Return113.38%135.48%268.2%

Avadel Pharmaceuticals PLC Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue22.33M-1.50M27.96M169.12M[{"date":"2020-12-31","value":13.21,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":0.88,"profit":true},{"date":"2023-12-31","value":16.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue5.74M815.00K1.49M846.00K15.28M[{"date":"2020-12-31","value":37.59,"profit":true},{"date":"2021-12-31","value":5.33,"profit":true},{"date":"2022-12-31","value":9.77,"profit":true},{"date":"2023-12-31","value":5.54,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit16.59M(815.00K)(1.49M)27.12M153.84M[{"date":"2020-12-31","value":10.79,"profit":true},{"date":"2021-12-31","value":-0.53,"profit":false},{"date":"2022-12-31","value":-0.97,"profit":false},{"date":"2023-12-31","value":17.63,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin74.29%-(99.80%)96.97%90.97%[{"date":"2020-12-31","value":76.61,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-102.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":93.8,"profit":true}]
Operating Expenses10.78M85.55M98.56M164.97M196.24M[{"date":"2020-12-31","value":5.49,"profit":true},{"date":"2021-12-31","value":43.59,"profit":true},{"date":"2022-12-31","value":50.22,"profit":true},{"date":"2023-12-31","value":84.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income5.82M(85.55M)(98.56M)(137.85M)(42.40M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1471.13,"profit":false},{"date":"2022-12-31","value":-1694.94,"profit":false},{"date":"2023-12-31","value":-2370.58,"profit":false},{"date":"2024-12-31","value":-729.13,"profit":false}]
Total Non-Operating Income/Expense(23.89M)(17.54M)(25.22M)(32.81M)(17.51M)[{"date":"2020-12-31","value":-2389100000,"profit":false},{"date":"2021-12-31","value":-1754100000,"profit":false},{"date":"2022-12-31","value":-2522000000,"profit":false},{"date":"2023-12-31","value":-3281400000,"profit":false},{"date":"2024-12-31","value":-1751000000,"profit":false}]
Pre-Tax Income(5.08M)(93.14M)(111.44M)(160.78M)(49.08M)[{"date":"2020-12-31","value":-508200000,"profit":false},{"date":"2021-12-31","value":-9314500000,"profit":false},{"date":"2022-12-31","value":-11143900000,"profit":false},{"date":"2023-12-31","value":-16077700000,"profit":false},{"date":"2024-12-31","value":-4907900000,"profit":false}]
Income Taxes(12.11M)(15.82M)26.02M(501.00K)(247.00K)[{"date":"2020-12-31","value":-46.53,"profit":false},{"date":"2021-12-31","value":-60.77,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.93,"profit":false},{"date":"2024-12-31","value":-0.95,"profit":false}]
Income After Taxes7.03M(77.33M)(137.46M)(160.28M)(48.83M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false},{"date":"2024-12-31","value":-694.82,"profit":false}]
Income From Continuous Operations7.03M(77.33M)(137.46M)(160.28M)(48.83M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false},{"date":"2024-12-31","value":-694.82,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income7.03M(77.33M)(137.46M)(160.28M)(48.83M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false},{"date":"2024-12-31","value":-694.82,"profit":false}]
EPS (Diluted)(0.56)(1.32)(2.25)(2.01)(0.52)[{"date":"2020-12-31","value":-56,"profit":false},{"date":"2021-12-31","value":-132,"profit":false},{"date":"2022-12-31","value":-225,"profit":false},{"date":"2023-12-31","value":-201,"profit":false},{"date":"2024-12-31","value":-51.73,"profit":false}]

Avadel Pharmaceuticals PLC Ratios

Avadel Pharmaceuticals PLC Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AVDL
Cash Ratio 1.47
Current Ratio 2.76
Quick Ratio 2.37

Avadel Pharmaceuticals PLC Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AVDL
ROA (LTM) -0.34%
ROE (LTM) -0.32%

Avadel Pharmaceuticals PLC Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AVDL
Debt Ratio Lower is generally better. Negative is bad. 0.51
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Avadel Pharmaceuticals PLC Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AVDL
Trailing PE NM
Forward PE 16.78
P/S (TTM) 8.50
P/B 21.51
Price/FCF 91
EV/R 8.14
EV/Ebitda 199.82
PEG 0.07

FAQs

What is Avadel Pharmaceuticals PLC share price today?

Avadel Pharmaceuticals PLC (AVDL) share price today is $21.5

Can Indians buy Avadel Pharmaceuticals PLC shares?

Yes, Indians can buy shares of Avadel Pharmaceuticals PLC (AVDL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AVDL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Avadel Pharmaceuticals PLC be purchased?

Yes, you can purchase fractional shares of Avadel Pharmaceuticals PLC (AVDL) via the Vested app. You can start investing in Avadel Pharmaceuticals PLC (AVDL) with a minimum investment of $1.

How to invest in Avadel Pharmaceuticals PLC shares from India?

You can invest in shares of Avadel Pharmaceuticals PLC (AVDL) via Vested in three simple steps:

  • Click on Sign Up or Invest in AVDL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Avadel Pharmaceuticals PLC shares
What is Avadel Pharmaceuticals PLC 52-week high and low stock price?

The 52-week high price of Avadel Pharmaceuticals PLC (AVDL) is $23.57. The 52-week low price of Avadel Pharmaceuticals PLC (AVDL) is $6.38.

What is Avadel Pharmaceuticals PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Avadel Pharmaceuticals PLC (AVDL) is

What is Avadel Pharmaceuticals PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Avadel Pharmaceuticals PLC (AVDL) is 21.51

What is Avadel Pharmaceuticals PLC dividend yield?

The dividend yield of Avadel Pharmaceuticals PLC (AVDL) is 0.00%

What is the Market Cap of Avadel Pharmaceuticals PLC?

The market capitalization of Avadel Pharmaceuticals PLC (AVDL) is $2.11B

What is Avadel Pharmaceuticals PLC's stock symbol?

The stock symbol (or ticker) of Avadel Pharmaceuticals PLC is AVDL

How Can Investors Use Avadel Pharmaceuticals PLC Share Price Data for Long-Term Investment Decisions?

Consider the share price of Avadel Pharmaceuticals PLC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Avadel Pharmaceuticals PLC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Avadel Pharmaceuticals PLC shares for Indian investors?

When investing in Avadel Pharmaceuticals PLC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Avadel Pharmaceuticals PLC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Avadel Pharmaceuticals PLC share price with other stocks in the same sector?

Rather than merely checking the share price of Avadel Pharmaceuticals PLC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Avadel Pharmaceuticals PLC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top